Delivery Order SPE2DR25D1017-SPE2DR26F9BVL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall 5 mg tablets (100-count units) with a ceiling value of $1,225.66. This non-set-aside, competitively awarded delivery order reflects a firm fixed-price contract type with an ultimate completion date of November 14, 2025. The award was issued on November 13, 2025, and represents a specific fulfillment request under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (quantity 100s) with a ceiling value of $1,266.02. The contract is firm fixed price with an ultimate completion date of September 11, 2025, and was awarded on September 10, 2025. This award carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $1,793.21 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) with a firm fixed price and a completion deadline of August 26, 2025. This non-set-aside, competitively awarded contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a $999.999 billion potential value through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall 5 mg tablets (100-count units) with a ceiling value of $6,330.10. This firm fixed-price contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a competitively awarded, non-set-aside procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and serves as a child order under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,838.49 to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100 count) with a completion date of December 1, 2025. This competitive award, made on November 28, 2025, utilizes firm fixed-price pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $4,048.85 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed-price contract. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of December 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the...
- The Defense Logistics Agency awarded a $1,838.49 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall 10 mg tablets in quantities of 100. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, represents a non-competitive set-aside contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $1,225.66 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Adderall 10 mg tablets in quantities of 100. This firm fixed-price contract, with an ultimate completion date of December 4, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Adderall 5 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,266.02 and an ultimate completion date of September 4, 2025. The contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,423.64 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets in quantities of 100 units. This firm fixed-price delivery order, awarded on December 12, 2025, with an ultimate completion date of December 15, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The performance location for this order is...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BVLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) with a ceiling value of $1,686.05. The contract, which is not set-aside, was competitively awarded on December 19, 2025, with an ultimate completion date of December 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order operates under a firm fixed-price arrangement, ensuring cost predictability for the government buyer. This award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/18/25 |